The probability that routine hematological laboratory tests of liver and pancreatic function can discriminate between malignant and benign pancreatic tumours, incidentally detected during operation, was investigated. The records of 53 patients with a verified diagnosis of pancreatic carcinoma and 19 patients with chronic pancreatitis were reviewed with regard to preoperative total bilirubin, direct reacting bilirubin, alkaline phosphatase, glutamyltranspeptidase, aminotransferases, lactic dehydrogenase and amylase. Multivariate and discriminant analysis were performed to calculate the predictive value for cancer, using SYSTAT statistical package in a Macintosh II computer. Total and direct reacting bilirubin and glutamyltranspeptidase were significantly higher in patients with pancreatic carcinoma. However, only considerably increased levels of direct reating bilirubin were predictive of pancreatic carcinoma.
INTRODUCTION
The diagnosis of pancreatic cancer is often difficult, even in the symptomatic patient1. Preoperatively the diagnosis usually is settled by means of computed tomography (CT) or ultrasound (US) and fine needle aspiration cytology (FNA) 2. Pancreatic carcinoma is reported to be complicated by obstructive 4 was used to compare laboratory data from the patients in the cancer group and the pancreatitis group. Factor analysis calculation was performed with varimax rotation to achieve and standardize an independent or orthogonal score for the predictors. This score was then used for calculations with the multiple general linear hypothesis program with models as described in text. All calculations were performed in a Macintosh II computer using SYSTAT5.
RESULTS
The results are summarized in Table 1 In a retrospective study 12 on 868 patients with inflammatory pancreatic disease 3% were jaundiced due to chronic pancreatitis and extrahepatic obstruction and 1.4% required surgical decompression. However, not only the magnitude but also the duration and progression of the bilirubin levels should be taken into consideration in the diagnosis of a pancreatic tumour 13 since a transitory periductular pancreatic oedema may account for elevation of bilirubin even in some patients with chronic pancreatitis12.
In the present study, S-ALP had elevated mean values in both the cancer patients and pancreatitis patients but did not differ between these groups. Seligson 14 found elevated S-ALP in 20 out of 24 patients with pancreatic malignancy which was significantly more common than in patients with chronic pancreatitis. However, elevation of S-ALP is not specific for pancreatic cancer since this can be found also in patients with other gastrointestinal tract cancers. Furthermore, biliary duct obstruction of any cause leads to elevation of S-ALP and may reflect that condition rather than be a marker of a specific disease of the pancreas islets5.
Amylase was within the limits of the normal range in most of the patients in the present study which is in accordance with the results presented by Fitzgerald 9 who found elevated amylase activity in the serum of only 14% of patients with pancreatic cancer, in 31% of patients with other gastrointestinal cancers and in 9% of patients with chronic pancreatitis. Thus amylase seems of merit only in the diagnosis of acute pancreatitis16.
The mean value of S-GT was above the upper reference limit in all patients in the present study, and significantly higher in the cancer patients compared to the pancreatitis patients. S-GT is distributed in different organs such as kidney, liver and pancreas. A specific S-GT seems to be present in pancreatic carcinoma cells17. Duct obstruction due to chronic pancreatitis increses S-GTTM. Collins et al. 19 demonstrated a low sensitivity and specificity of S-GT in the differential diagnosis of jaundice.
In conclusion we found that jaundice was not frequent in patients with chronic pancreatitis. Although an elevation in routine hematological laboratory tests of liver and pancreatic function was common in the patients in the present study, only considerably raised levels of direct reacting bilirubin seemed to be of value in predicting cancer when a tumour was found in the head of pancreas. The discrepancy in the results of different studies evaluating diagnostic accuracy of routine biochemical tests in the diagnosis of pancreatic tumours may, to some extent, be explained by differences in laboratory techniques and variability in patients groups. In the individual patient, however, the final diagnosis and decision of resection should be achieved by mean of FNA or HPE. 
